Chronic pain clinical trials in Barrie, Ontario
Part of chronic pain trials in Ontario.
3
Trials
0
Recruiting or not yet
3
Trial sites
Trials with a site in Barrie
3 trials, recruiting first
| Phase | ||||
|---|---|---|---|---|
| A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain NCT01060254 | Terminated | Phase 2 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-04-06 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy NCT01041859 | Completed | Phase 3 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-12 |
| An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis NCT00826514 | Completed | Phase 2 | Pfizer | 2009-03-25 |
Facilities listed in the registry
- The Male/Female Health and Research Centre (1 trial site)
Facility names are as entered by study registrants. This is not a clinic directory.
Map
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.